Highlights<'/> Electrochemical treatment of anti-cancer drug carboplatin on mixed-metal oxides and boron doped diamond electrodes: Density functional theory modelling and toxicity evaluation
首页> 外文期刊>Journal of Hazardous Materials >Electrochemical treatment of anti-cancer drug carboplatin on mixed-metal oxides and boron doped diamond electrodes: Density functional theory modelling and toxicity evaluation
【24h】

Electrochemical treatment of anti-cancer drug carboplatin on mixed-metal oxides and boron doped diamond electrodes: Density functional theory modelling and toxicity evaluation

机译:混合金属氧化物和掺硼金刚石电极上抗癌药物卡铂的电化学处理:密度泛函理论建模和毒性评价

获取原文
获取原文并翻译 | 示例
           

摘要

HighlightsThe electrooxidation of anti-cancer drug CrbPt by MMO and BDD electrodes has been studied.The most effective anode was found as Ti/RuO2with the complete degradation of CrbPt.The degradation of CrbPt significantly increased with increasing current density.DFT calculations show the formation of [Pt(NH3)2(H2O)2]2+and [Pt(NH3)2(OH)2].The results showed that Ti/RuO2anode provided zero toxicity at the end of the process.AbstractThis study represents the electrooxidation of anti-cancer drug carboplatin (CrbPt) with different mixed metal oxide (MMO) and boron doped diamond (BDD) electrodes. The most effective anode was found as Ti/RuO2with the complete degradation of CrbPt in just 5min. The effect of applied current density, pH and electrolyte concentration on CrbPt degradation has been studied. The degradation of CrbPt significantly increased at the initial stages of the process with increasing current density. However, further increase in current density did not affect the degradation rate. While complete degradation of CrbPt was provided at pH 7, the degradation rates were 49% and 75% at pH 9 and 4, respectively. Besides, increasing supporting electrolyte (Na2SO4) concentration provided higher degradation rate but further increase in Na2SO4concentration did not provide higher degradation rate due to excess amount of SO4−2. According to the DFT calculations, the formation of [Pt(NH3)2(H2O)2]2+and [Pt(NH3)2(OH)2] takes place with molecular weights of 265 and 263gmol−1, respectively. Toxicity of treated samples at BDD and Ti/RuO2electrodes has been also evaluated in this study. The results showed that Ti/RuO2anode provided zero toxicity at the end of the process.
机译: 突出显示 已研究了MMO和BDD电极对抗癌药物CrbPt的电氧化作用。 发现最有效的阳极为Ti / RuO 2 ,并且CrbPt完全降解。 CrbPt的降解随着电流密度的增加而显着增加。 DFT计算显示了[Pt(NH 3 2 (H 2 O) 2 ] 2 + 和[Pt(NH 3 2 (OH ) 2 ]。 结果显示Ti / RuO 2 阳极提供了零在该过程结束时产生毒性。 摘要 这项研究代表了抗癌药物卡铂(CrbPt)的电氧化作用与混合金属氧化物(MMO)和掺硼金刚石(BDD)电极。发现最有效的阳极为Ti / RuO 2 ,而CrbPt仅在5分钟内即可完全降解。研究了施加电流密度,pH和电解质浓度对CrbPt降解的影响。随着电流密度的增加,CrbPt的降解在过程的初始阶段显着增加。但是,电流密度的进一步增加不会影响降解速率。尽管在pH 7时CrbPt完全降解,但在pH 9和4时降解率分别为49%和75%。此外,增加支持电解质(Na 2 SO 4 )的浓度可提供更高的降解率,但进一步降低Na 2 SO 4 浓度的增加由于过量的SO 4 -2 。根据DFT计算,[Pt(NH 3 2 (H 2 O) 2 ] 2+ < / ce:sup>和[Pt(NH 3 2 (OH) 2 ]的分子量分别为265和263gmol -1 。这项研究还评估了处理样品在BDD和Ti / RuO 2 电极上的毒性。结果表明,Ti / RuO 2 阳极在过程结束时提供了零毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号